The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Momenta Pharmaceuticals Inc

Nasdaq: MNTA
Last

(U.S.) $14.00

Today's change0.00 0.00%
Updated April 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Momenta Pharmaceuticals Inc

Nasdaq: MNTA
Last

(U.S.) $14.00

Today's change0.00 0.00%
Updated April 26 4:00 PM EDT. Delayed by at least 15 minutes.

Momenta Pharmaceuticals Inc closed at (U.S.)$14.00.

Over the last five days, shares have gained 6.46%, but are down 6.98% for the last year to date. Shares have outperformed the S&P 500 by 36.24% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $14.00
  • High--
  • Low--
  • Bid / Ask-- / --
  • YTD % change-6.98%
  • Volume0
  • Average volume (10-day)566,770
  • Average volume (1-month)646,914
  • Average volume (3-month)724,770
  • 52-week range(U.S.) $8.82 to (U.S.) $19.90
  • Beta1.81
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.31
Updated April 26 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue34292620
Total other revenue--------
Total revenue34292620
Gross profit--------
Total cost of revenue--------
Total operating expense45474844
Selling / general / administrative18161516
Research & development26323329
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-10-18-22-25
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax42-18-21-24
Income after tax42-18-21-24
Income tax, total--------
Net income42-18-21-24
Total adjustments to net income--------
Net income before extra. items42-18-21-24
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items42-18-21-24
Inc. avail. to common incl. extra. items42-18-21-24
Diluted net income42-18-21-24
Dilution adjustment------0
Diluted weighted average shares69696968
Diluted EPS excluding extraordinary itemsvalue per share0.60-0.26-0.31-0.35
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.60-0.26-0.31-0.35